LECTURE 3: ADHD Flashcards

1
Q

Disorders of Childhood Origin

A

• Disorders which are typically diagnosed in
the developmental period are called
neurodevelopmental disorders.
• Neurodevelopmental disorders include:
o Intellectual disabilities
o Communication disorders
o ASD
o ADHD
o Specific learning disorders
o Motor disorders
o Tic disorders
• Children can experience adult-associated
disorders like anxiety, depression, bipolar, or
schizophrenia but the onset typically doesn’t
occur during the developmental period.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Three Most Common Neurodevelopmental Disorders: (often comorbid)

Disorder
Core Features
Pharmacological Agent

A
ADHD	
• Deficits in attention, impulse control, 
   and/or hyperactivity
• Stimulants
• Non-stimulants

Tourette’s Disorder
• Presence of both vocal and motor tics
• Antipsychotic
• Adrenergic alpha-2 medications

ASD
• Persistent deficits in social communication
and social interactions, and a pattern of
restricted and repetitive behaviors
• Antipsychotic medication

  • Pharmacological interventions can treat
    (modulate the expression) symptoms but
    not cure these conditions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Prevalence

General

A
One-fourth of children worldwide have experienced a mental disorder in the past year (25%) and one-third in their lifetime.
1.	Anxiety disorders (most common)
2.	Behavior
3.	Mood
4.	Substance use disorders (least 
        common)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ASD Rate in 2020: USA

A
  • 1 in 34 among boys (or 2.97 percent)
  • 1 in 145 among girls (or 0.69 percent)
  • Boys > Girls
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

SES

A

• 50% of children in the child welfare system
meets the criteria for a mental disorder
1. Neurodevelopmental behaviour
disorders (i.e., conduct and oppositional
defiant disorder and ADHD)
2. Neurodevelopmental Anxiety and Mood
disorders (i.e., depressive disorders)
• Low SES > High SES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Cross-cultural Studies

A

• Higher rates of internalizing disorders
(anxiety) among girls
• Higher rates of externalizing disorders
among boys (behavior disorders)
• Australia, China, Israel, Jamaica,
Netherlands, Turkey, and United States

*Gender difference found worldwide
*Girls > Boys in internalizing anxiety
prevalence
*Boys > Girls in external behaviour disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Attention Deficit Hyperactivity Disorder (ADHD)

Definition

A

• Persistent pattern of inattention and/or
hyperactivity and impulsivity
o Impairment in settings such as school and
work
o Onset of symptoms occurs in childhood
o According to the DSM-5 several
inattention and hyperactivity-impulsivity
symptoms need to occur prior to age 12.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

(3) ADHD Subtypes

A

• Predominately inattentive (40% of cases;
more common in girls > boys)
• Predominately hyperactive-impulsive (very
small percentage; boys > girls)
• Combined presentation (50-55%; boys >
girls)

*Three common symptoms of ADHD are
Attentional Deficits and
Hyperactivity/Impulsivity.
Symptoms emerge in childhood and disrupt
schooling (student-teacher interactions,
disruptive behaviour, poor academic
performance) but by adulthood the
symptoms become more manageable.
ADHD behavioural symptoms are modifiable
but the disorder is not curable.
*Women more likely to be diagnosed in
adulthood than men (more likely to be
diagnosed with other internalizing disorders
first; anxiety or depression)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Prevalence

ADHD

A

• ADHD occurs worldwide!
• Affects ~5% of children and ~2.5% of adults
• The disorder is more frequently diagnosed
in males than females but the male to
female ratio ranges from 2:1 to 9:1
depending on subtype.
• ADHD is the most common
neurodevelopmental disorder and most
commonly studied.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Percent of children with a parent-reported ADHD diagnosis

A

• The prevalence of ADHD is increasing 5%
annually with 6.4 million children in the US
meeting the criteria for ADHD.
• ADHD is becoming more common,
prevalence rates is increasing, upwards
trend.
• Why? Many theories exist. Difference in
diagnosis criteria, becoming more aware of
the condition, how to spot it and more
people getting assessed by child
psychologists. Environmental factors? It
could be many things; the jury is still out on
a firm conclusion.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Comorbidity (disorders)
Comorbidity (outcomes)
ADHD

A
Comorbidity (disorders)
*High comorbidity (ADHD doesn’t present 
 alone; makes diagnosis and treatment more 
 complicated)
•	Conduct disorder
•	Oppositional defiant disorder
•	Tourette’s disorder
•	Mood disorders
•	Learning disabilities
Comorbidity (outcomes)
• Children and adults with ADHD have a 
   greater risk of:
o	Academic deficits
o	School-related problems
o	Social skill deficits
o	Peer rejection 
• Adolescents with ADHD have a greater risk 
  of:
o	Antisocial behavior 
o	School dropout
o	Small percentage of adolescents with 
        ADHD pursues higher education 
• College students with ADHD do not differ 
   in intelligence 
o	However, more likely to have a lower 
        GPA 
o	Report greater difficulty paying 
        attention in lectures 
o	Greater risk of depression and/or 
        anxiety disorders
o	Have lower quality of life 
• Adults with ADHD report problems with:
o	Employment
o	Sexual Relationships
o	Driving
o	Illegal activities 
o	Depression or personality disorders

*ADHD symptoms linked to these poorer
outcomes (not due to intelligence! It’s the
consequence of in attention or hyperactivity
impair school engagement, and being
different from other kids impairs social
relationships)
*GPA lower due to engagement not
intelligence!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ADHD in prisoners

A

• ADHD is common among Norwegian
prison inmates
• ADHD is a risk factor for substance abuse
in adults and individuals with ADHD tend to
become addicted more rapidly and
severely
• ADHD is positively associated with
persistent cigarette smoking
• Greater internal restlessness and more
likely to have executive function deficits
(not unique to ADHD)

*Prisoners have ADHD (links to the illegal
activity points; problems with MH since
childhood led to poorer life outcomes like
prison)
*Pre-frontal cortex impairments, impulse
control disorders and risk of addiction (one
reason for ADHD but not the only factor).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Is ADHD Advantageous?

A

• There is a popular myth that ADHD is
beneficial.
• There is no evidence to support that
children with ADHD have superior divided
attention skills
• ADHD is a chronic disorder that causes
impairment in social, occupational, and
academic functioning

*Some people say ADHD is an advantage.
They argue that they can do so many tasks
because they can split their attention
between them. This is NOT true. For almost
everyone, there is evidence to support that
splitting attention between tasks impairs
performance. People with ADHD do not do
better at multitasking than HC’s

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q
Genetics
Family Studies (ADHD
A

• ADHD is more common in individuals with
first or second degree relatives with ADHD
(5-10x risk)
• More frequent among siblings who shared
the same mother and father (increased risk
between biological relative to step siblings)
• Individuals with ADHD are more likely to
have siblings with ADHD, having one
biological parent with ADHD their children
had an increased risk of 57%
• Adoptive relatives are less likely to have
ADHD than biological relatives (nature not
nurture)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Twin Studies (ADHD)

A

• ADHD is more common in identical twins
compared to fraternal twins
• Correlation of 0.78 (monozygotic) and 0.45
for (dizygotic)
• Despite girls with ADHD showing less
behavioural problems than boys their
heritability estimates are similar
• The overall heritability rate for ADHD is
0.70-0.80 which is substantially higher than
other psychiatric disorders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

In-Class Discussion

Is ADHD binary?
Are labels good?
Why short term use of stimulants?

A

• Huge genetic component.
• Very high genetic risk between identical
twins (monozygotic) which tells us it is due
to nature rather than nurture.
• There are some important environmental
risk factors (mother that smoked while
pregnant, low birth weight, pollution during
prenatal development).
• There is no single cause, multiple causes or
origins can lead to the same
symptomology. TBI can result in ADHD (less
common cause).
• It doesn’t typically manifest in adulthood,
the symptoms are typically present in
childhood but not diagnosed.
• Awareness of ADHD symptoms through
tiktok can help women stop internalizing
symptoms, discrediting them, blaming
themselves for being lazy. Still should not
self-diagnose but need to go to a
psychologist.
• ADHD is a spectrum disorder
(high/moderate/low; heterogenous
presentation of symptoms) not binary (have
It or don’t; categorical; DSM-5). Diagnosis
requires 6 symptoms in the one category.
• What’s misunderstood about ADHD?
Education perspective think MH labels are
harmful for kids, stigma, impact how
teachers treat students, should frame it in
terms of strengths and areas of need
without the labels. In contrast, people with
ADHD really liked the label, removed self-
blame and guilt about not being able to do
certain tasks. With or without the label the
teacher would respond differently to
children with ADHD, labels help educate
teachers that there is biological reasons for
their different behaviour and not the child’s
fault. More empathetic, give better support
to the child.
• Medication (from neuroscience view; from
brain perspective illegal and Adderall are
the same effect on the brain) her view the
effectiveness of riddelliine is effective in
increasing attentional focus, academic
achievement (positive effects) there is also a
lot of research on long-term effects being
limited (immediate short-term benefits on
academic performance but it wanes over
time over the first couple of years; there are
side effects of stunted growth/shorter
height, apatite suppression and weight loss,
emotional outburst). For students with
severe symptoms behavioural interventions
are not effective without stimulants to help
them regulate their attention, without
behavioural intervention to teach them to
manage their symptoms long-term what is
the point of providing stimulants? There is a
tolerance build up with developmental
changes where dosage needs to be
adjusted. These medications are not as
easily accessible worldwide (stimulant
prescribed in NZ but not Japan; non-
stimulants are more tolerable than
stimulants but is not as impactful and ess
symptoms)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Candidate genes

ADHD

A

• Controversial and contradictory results
• Due to ADHD’s symptoms of inattention,
hyperactivity, and impulsivity being in the
prefrontal region studies have focused on
the role of dopamine genes in the etiology
of ADHD
• Polymorphisms of Dopamine Genes
studied include:
o Postsynaptic dopamine receptors (DRD4,
DRD5)
o Presynaptic dopamine transporter proteins
(DAT1)

18
Q

Postsynaptic dopamine receptors (DRD4, DRD5)

ADHD

A

• DRD4 gene is located on chromosome 11
and encodes the D4 version of the
dopamine receptor and is activated by
dopamine. Primarily located in the
mesolimbic and prefrontal regions.
• 120bp repeat, DRD4 polymorphism
associated with increased risk of
developing ADHD
• Children with a specific type of DRD4 gene
who were exposed to pesticides have an
increased risk of ADHD (e.g., rs752306)
• Several polymorphisms of DRD5 have
been found to occur more frequently in
individuals with ADHD. DRD5 is located on
chromosome 4 and widely distributed
throughout the brain.
• Mixed findings!

19
Q

Presynaptic dopamine transporter proteins DAT1 (aka. SLC6A3 gene)

ADHD

A

• DAT1 gene is located on chromosome 5
and encodes the transporter protein for
dopamine.
• Polymorphisms of the DAT1 gene are more
common in individuals with ADHD.
• DAT1 transporter proteins are embedded in
the cell membrane of the presynaptic cell
and is responsible for the reuptake of
dopamine from the synaptic cleft following
exocytosis.

20
Q

Methylphenidate

ADHD

A

• Relationship between polymorphism of
SLC6A3 (10-repeat VNTR) and a positive
response to methylphenidate.
o Polymorphisms of the SLC6A3 gene leads
to overactivity of dopamine transporters in
children with ADHD and helps explain the
effectiveness of methylphenidate in
treating ADHD; because methylphenidate
blocks the dopamine transporter protein.

21
Q

Genome-wide association studies

A

• Serotonin genes have been implicated in
ADHD
• Variations of SLC6A4 gene increase risk of
ADHD
o SLC6A4 is located on chromosome 17 and
encodes the serotonin transporter protein
that removes serotonin from the synaptic
cleft (reuptake)
§ SSRIs which target and block serotonin
transporters to prevent reuptake are
sometimes effective at treating ADHD
§ COMT, SNAP25, SDRA2 have been
explored

22
Q

Etiology

A

• Dopamine and serotonin genes may be
involved in the etiology of ADHD by altering
neurotransmitter systems and functional
connectivity in individuals with ADHD
(controversial)
• Studies identifying single genes associated
with ADHD have been small, rare, mixed, or
implicated in other disorders suggesting
that ADHD is likely caused by complex
interactions of genetic and environmental
risk factors
• Genes cannot be used to predict the risk of
ADHD beyond familial history

*ADHD is likely to be the result of a complex
interaction between multiple genes and the
environment

23
Q

Structural Findings
MRI studies have produced mixed findings on brain structural differences between Individuals with and without ADHD.

Brain volume
Structural Volume reductions
Structural findings (controversial)

A

Brain volume
• Total brain volume is 5% smaller in boys
with ADHD
• Caudate nucleus is significantly larger
o Caudate nucleus is rich in dopamine
neurons
§ Stimulant medication (i.e.,
methylphenidate) used to treat ADHD
increases activity in the caudate nucleus
which results in reduced behavioural
symptoms

Reading:
- The affected twin with ADHD (but not the
unaffected twin) shows smaller caudate
volumes. However, another study found
both twins (with and without ADHD) had
volume reductions in the prefrontal and left
occipital regions and the right cerebellar
volume was significantly smaller in those
with ADHD.
- These findings suggest that biological
vulnerability to ADHD does not explain why
some people do or do not develop ADHD.
- These morphological (structural) findings
support genetic findings claims that
dopamine in ADHD.

Structural Volume reductions
•	Globus pallidus
•	Striatum
•	Cerebellum
•	Prefrontal cortex
•	Corpus callosum

Structural findings (controversial)
• Longitudinal study found that children with
ADHD reach peak levels of cortical
thickness ~3 years later than healthy
controls (slower rate). Specifically, in
regions associated with motor and
executive function.
• Asymmetry of basal ganglia
• Cortical thinning, reduced gray matter and
white matter connectivity

*Indicating that multiple brain regions and
structure alterations are implicated in the
ADHD. However, findings on which
structures and their cause are mixed. To
date, no structural differences can be
reliably used to diagnose ADHD.

24
Q

Functional Findings

Methylphenidate

A

Methylphenidate
• ADHD is associated with reduced blood
flow in the frontal lobe and basal ganglia.
However, post administration of
methylphenidate is associated with
increases in blood flow in the frontal lobe
and basal ganglia.
• Methylphenidate has different
physiological effects on children with and
without ADHD:
o Increased activity in the striatum (ADHD)
o Decreased activity in the striatum (No-
ADHD)
o Increased activity in the frontal lobes
(ADHD & No-ADHD)

Reading:
- Boys with ADHD have increased blood
flow in the striatum but administering
methylphenidate reduced this activity.
- Methylphenidate modulates basal ganglia
and frontal lobe activity and increases
regional cerebral blood flow in these
regions. These functional changes are
associated with symptom reduction.

So …
• These functional findings support structural
findings that there is abnormal striatal-
frontal circuitry in children with ADHD.

Reading:
- Faulty striatal-frontal circuitry maybe
modulated by gene variants of the
dopaminergic system. For example, higher
regional cerebral blood flow in the medial
frontal and left basal ganglia following the
administration of methylphenidate in
children with ADHD and the DAT1
dopamine gene.

25
Q

Functional

Glucose activity

A
•	Mixed findings
•	Reduced in the prefrontal regions while 
        performing tasks that require 
o	Planning
o	Working memory
o	Decision making

Reading:
- 8.1% reduced glucose metabolism in the
prefrontal and premotor regions
- Reduced glucose metabolism in the left
frontal lobe is inversely correlated with
ADHD symptom severity (i.e., as glucose
metabolism decreases symptom severity
increases)
- Reduced glucose metabolism in the
striatum in adults with ADHD (especially
females)

26
Q

Functional

Dopamine receptor density

A

• Increased postsynaptic dopamine receptor
availability (D2, D3) in adolescents with
ADHD who had low cerebral blood flow as
neonates (cerebral ischemia is a risk factor
of ADHD)
• Decreased density of dopamine
transporters in the striatum (presynaptic;
mixed finding)

Reading:
- Decreased dopamine receptor availability
(D2, D3) and cortical thinning in drug naïve
adults with ADHD
- Chronic (3 months) Methylphenidate
administration in male children with ADHD
and found a 20% down regulation of
postsynaptic dopamine receptors (reduced
availability, sensitivity to neurotransmitters
which increases the release of dopamine)
and a 74% reduction of dopamine
transporter in the striatum. Dopamine
receptor reduction was associated with
improved ADHD symptoms.

27
Q

Neuroplasticity speculation?

A
• Faulty mechanisms of neuroplasticity may 
  contribute to the development of ADHD 
o Prescription stimulants (similar to 
   antidepressants) may promote 
   neuroplasticity:
• Increased dendrite length and branching 
  neurons in the frontal lobe
• Growth and expansion of neurons
• Axon regeneration
o Studies are sorely needed! Previous 
   findings are with animal model.
28
Q

Summary: Genetic, Structural and Functional Findings-

A

• Structural and functional findings indicate
the frontal-striatal region in ADHD
• ADHD is likely to be the result of complex
structural and functional abnormalities
including catecholaminergic deficiency (.
reduced dopamine)
• Highly genetic
• Gene-Environment interaction
• Environmental factors include prenatal
nutritional factors and life stress can change
DNA (methylation and in histone
modification levels) that effect gene
expression and increases the risk of ADHD.

29
Q

Pharmacological interventions

A

• Two-thirds (3.5 million) of ADHD children
are prescribed psychostimulants in the US
• Psychostimulants: Most used and effective
medications
• Three types of Pharmacological
interventions: stimulants, non-stimulants
and prostimulants
• Their effectiveness depends on age,
symptom severity, and duration of
symptoms
• ~20 - 30% of children do not show
improvement and alternative medications
are used – antidepressants or
anticonvulsants.

30
Q

Psychostimulants

A

• ADHD (children & adults)
o Methylphenidate
o Amphetamine derivatives
o ADHD is estimated to affect 3% to 7% of
the school-age population and 4% of
adults worldwide
 Blocks the transporter protein for
dopamine (DAT) resulting in more
dopamine available in the synaptic cleft
and helps to regulate dopaminergic
systems, particularly in the regions of
the prefrontal cortex and basal ganglia.

31
Q

Biomarkers for effectiveness of stimulants

A

• There are no reliable biomarkers to identify
which children will respond positively to
stimulants!
o Polymorphisms of dopamine,
norepinephrine, and noradrenaline genes
may result in poorer response to stimulants
o The degree of activation in the caudate
nucleus may be predictive of superior
response to methylphenidate (over
atomoxetine)

32
Q

Non-pharmacological approaches

A

• Behavioral interventions for children under
the age of six is recommended clinical
practice (prior to medication)
o Behavioral support programs
o Educational interventions
o Counseling
• More children are treated with medication
relative to behavioural treatment (62% vs
46.7%) and 23% were untreated.

33
Q

Why give stimulants/non-stimulants?

A
  • Adderall, amphetamine salts, or Ritalin.
  • Reuptake receptor (pre-synaptic) is
    blocked to increase dopamine levels. The
    biochemical problem with children is that
    there is not enough dopamine in their
    system. All these drugs do is block
    reuptake of dopamine to increase
    dopamine levels and reduce ADHD
    behavioural symptoms. The same as giving
    a kid Adderall or cocaine they both
    increase dopamine in synaptic cleft and
    increase binding to post-synaptic cell.
  • We cannot cure ADHD, need to combine
    CBT with medication to get the best
    outcomes for children diagnosed with
    ADHD.
34
Q

Safety of prescription stimulants

A

• Appear to be safe (preschoolers, children,
adolescents, and adults)
• Not associated with increased risk of
substance abuse
• Can induce sleep disturbances (minor to
severe)

Recap:
- Stimulants such as methylphenidate (Ritalin)
increase arousal levels of the CNS primarily
blocking the dopamine transporter (DAT)
thereby increasing the availability of
dopamine in the extracellular fluid.
- There is a common misconception that
stimulants have a paradoxical effect – that
is, they calm a hyperactive system. In
contrast, evidence shows that children with
ADHD have an under-aroused system.
- Stimulants increase arousal and help to
regulate frontal-striatal pathways believed
to be dysfunctional in ADHD.

35
Q

Anticonvulsants and antidepressants

A

• When stimulants fail
• When comorbid disorders are present such
as OCD and Depression
• E.g., tricyclic antidepressants, SSRIs
(comorbid OCD, depression and mood
problems), bupropion (SNRI)

36
Q

Medications

A

• Methylphenidate more effective than
atomoxetine and guanfacine
• Lisdexamfetamine is more likely to cause
sleep disorders (39%) as well as loss of
appetite (65%) and behavior problems, such
as irritability (60%)
• Fewest adverse events are associated with
reboxetine
• Stimulants more effective than
antidepressants

37
Q

Non-pharmacological interventions (behavioural & psychosocial)

A

• Questions remain about the effectiveness
and safety of these therapies because they
have not been studied as much as
medication trials.
• Examples include:
o Dietary modifications (most common
alternative treatment)
o Nutritional supplements
o Biofeedback
o Caffeine
o Homeopathy
• 69% took medication, 64% of people use
alternative therapies but only 11% discuss
using these methods with their child’s
physician

38
Q

Nutritional supplements / dietary restrictions
Non-pharmacological interventions
Neurofeedback
Anthroposophical Treatments

A

Nutritional supplements / dietary restrictions
• Conflicting results! (reduced or no effect on
symptoms)
• Results have failed to support the
hypothesis that ADHD is driven by dietary
micronutrient

Non-pharmacological interventions
• Caffeine vs. stimulants
o Stimulants are significantly more effective
at reducing symptoms
o Some researchers recommend the
adjunctive use of caffeine with stimulants

Neurofeedback
• Reported to effectively reduce ADHD
symptomology (controversial)
• Lack of methodological rigor

Anthroposophical Treatments
• Massage therapy and acupuncture show
preliminary benefits in reducing ADHD
symptoms but lack methodological rigor

39
Q

Final ADHD remarks:

A

Jackson Pollock, when we look at the brain, there is order in the chaos. We know there is neurological causes for the behavioural problems for these disorders. A lot is largely unknown, we can use medication or brain stimulation to improve behaviour but we do not know why. We do not have definitive causal explanations and cures for mental disorders. All behaviour comes from the physiology, and our physiology is a mess (its complicated)

40
Q

ADHD Summary:

A
• Highly genetic
• Dopamine and serotonin gene 
  polymorphisms implicated
• No single ADHD gene! Likely to be a 
  complex interaction of several
• Dysfunctional frontal-striatal circuitry in 
  ADHD
• Stimulants (pharmacological) treatments are 
  most effective
• No biomarkers (ADHD and treatment 
  effectiveness)
• Alternative treatments are available but 
  produce mixed findings